Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Van Geel

Showing results (131-140 of 172) with videos related to

Pageof 18
Sort By:
British Journal of Cancer|June 11, 2024
Proactive monitoring of drug-drug interactions between direct oral anticoagulants and small-molecule inhibitors in patients with non-small cell lung cancerJudith L Gulikers, Leila-Sophie Otten, Lizza E L Hendriks, et al.
The Journal of Clinical Endocrinology and Metabolism|March 18, 2011
Contributors to secondary osteoporosis and metabolic bone diseases in patients presenting with a clinical fractureSandrine P G Bours, Tineke A C M van Geel, Piet P M M Geusens, et al.
The British Journal of Dermatology|February 3, 2009
Wilms tumour as a possible early manifestation of hereditary leiomyomatosis and renal cell cancer?S Badeloe, K Y van Spaendonck-Zwarts, M A M van Steensel, et al.
Neurocritical Care|May 25, 2013
Hypothermia after CPR prolongs conduction times of somatosensory evoked potentialsAline Bouwes, Patty G G Doesborg, D Martin Laman, et al.
Lung Cancer (Amsterdam, Netherlands)|February 23, 2016
Crizotinib-induced fatal fulminant liver failureRobin M J M van Geel, Jeroen J M A Hendrikx, Jelmer E Vahl, et al.
Journal of Medical Genetics|November 3, 2004
FRG2, an FSHD candidate gene, is transcriptionally upregulated in differentiating primary myoblast cultures of FSHD patientsT Rijkers, G Deidda, S van Koningsbruggen, et al.
Plos One|November 9, 2013
Comparing tolerability and efficacy of generic versus brand alendronate: a randomized clinical study in postmenopausal women with a recent fractureJoop P W van den Bergh, Marian E Bouts, Eveline van der Veer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 17, 2023
Expanding the molecular and clinical spectrum of autosomal recessive congenital ichthyosis caused by pathogenic variants in NIPAL4 and PNPLA1 and evaluation of novel therapeutic interventionsS V J Rossel, J M K Clabbers, P M Steijlen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Phase II Study of WEE1 Inhibitor AZD1775 Plus Carboplatin in Patients With TP53-Mutated Ovarian Cancer Refractory or Resistant to First-Line Therapy Within 3 MonthsSuzanne Leijen, Robin M J M van Geel, Gabe S Sonke, et al.
Biomedical Chromatography : BMC|March 20, 2023
Development and validation of an HPLC-MS/MS method to simultaneously quantify brigatinib, lorlatinib, pralsetinib and selpercatinib in human K2-EDTA plasmaJudith L Gulikers, Ard J van Veelen, Elishia M J Sinkiewicz, et al.
Pageof 18

Showing results (131-140 of 172) with videos related to

Sort By:
Pageof 18
British Journal of Cancer|June 11, 2024
Proactive monitoring of drug-drug interactions between direct oral anticoagulants and small-molecule inhibitors in patients with non-small cell lung cancerJudith L Gulikers, Leila-Sophie Otten, Lizza E L Hendriks, et al.
The Journal of Clinical Endocrinology and Metabolism|March 18, 2011
Contributors to secondary osteoporosis and metabolic bone diseases in patients presenting with a clinical fractureSandrine P G Bours, Tineke A C M van Geel, Piet P M M Geusens, et al.
The British Journal of Dermatology|February 3, 2009
Wilms tumour as a possible early manifestation of hereditary leiomyomatosis and renal cell cancer?S Badeloe, K Y van Spaendonck-Zwarts, M A M van Steensel, et al.
Neurocritical Care|May 25, 2013
Hypothermia after CPR prolongs conduction times of somatosensory evoked potentialsAline Bouwes, Patty G G Doesborg, D Martin Laman, et al.
Lung Cancer (Amsterdam, Netherlands)|February 23, 2016
Crizotinib-induced fatal fulminant liver failureRobin M J M van Geel, Jeroen J M A Hendrikx, Jelmer E Vahl, et al.
Journal of Medical Genetics|November 3, 2004
FRG2, an FSHD candidate gene, is transcriptionally upregulated in differentiating primary myoblast cultures of FSHD patientsT Rijkers, G Deidda, S van Koningsbruggen, et al.
Plos One|November 9, 2013
Comparing tolerability and efficacy of generic versus brand alendronate: a randomized clinical study in postmenopausal women with a recent fractureJoop P W van den Bergh, Marian E Bouts, Eveline van der Veer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 17, 2023
Expanding the molecular and clinical spectrum of autosomal recessive congenital ichthyosis caused by pathogenic variants in NIPAL4 and PNPLA1 and evaluation of novel therapeutic interventionsS V J Rossel, J M K Clabbers, P M Steijlen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Phase II Study of WEE1 Inhibitor AZD1775 Plus Carboplatin in Patients With TP53-Mutated Ovarian Cancer Refractory or Resistant to First-Line Therapy Within 3 MonthsSuzanne Leijen, Robin M J M van Geel, Gabe S Sonke, et al.
Biomedical Chromatography : BMC|March 20, 2023
Development and validation of an HPLC-MS/MS method to simultaneously quantify brigatinib, lorlatinib, pralsetinib and selpercatinib in human K2-EDTA plasmaJudith L Gulikers, Ard J van Veelen, Elishia M J Sinkiewicz, et al.
Pageof 18